Literature DB >> 26596917

Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors.

Talha A Malik1.   

Abstract

Inflammatory bowel disease (IBD) describes a group of closely related yet heterogeneous predominantly intestinal disease processes that are a result of an uncontrolled immune mediated inflammatory response. It is estimated that approximately one and a half million persons in North America have IBD. Pathogenesis of IBD involves an uncontrolled immune mediated inflammatory response in genetically predisposed individuals to a still unknown environmental trigger that interacts with the intestinal flora. There continues to be an enormous amount of information emanating from epidemiological studies providing expanded insight into the occurrence, distribution, determinants, and mechanisms of inflammatory bowel disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crohn's disease; Epidemiology; Historical perspective; Inflammatory bowel disease; Risk factors; Ulcerative colitis

Mesh:

Year:  2015        PMID: 26596917     DOI: 10.1016/j.suc.2015.07.006

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  39 in total

1.  A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease.

Authors:  Xi-Yue Tan; Yu-Jia Xie; Xing-Long Liu; Xin-Yun Li; Bo Jia
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-26       Impact factor: 2.650

2.  Analysis of the Therapeutic Effect of Changyanning on Intestinal Flora in Inflammatory Bowel Disease.

Authors:  Xinyu Hu; Fuyuan Yang
Journal:  Contrast Media Mol Imaging       Date:  2022-06-22       Impact factor: 3.009

Review 3.  Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.

Authors:  Yao Chen; Xiang Wang
Journal:  Brain Behav       Date:  2021-05-07       Impact factor: 2.708

4.  Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers.

Authors:  Xi-Xi Wu; Xie-Lin Huang; Ru-Ru Chen; Tang Li; Hua-Jun Ye; Wei Xie; Zhi-Ming Huang; Gao-Zhong Cao
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

Review 5.  Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach.

Authors:  George P Christophi; Arvind Rengarajan; Matthew A Ciorba
Journal:  Clin Exp Gastroenterol       Date:  2016-05-19

Review 6.  Making sense of the cause of Crohn's - a new look at an old disease.

Authors:  Anthony W Segal
Journal:  F1000Res       Date:  2016-10-12

Review 7.  Ophthalmic manifestations in patients with inflammatory bowel disease: A review.

Authors:  Leandro Lopes Troncoso; Ana Luiza Biancardi; Haroldo Vieira de Moraes; Cyrla Zaltman
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

Review 8.  High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases.

Authors:  Mamie Gao; Allen Zhong; Neil Patel; Chiraag Alur; Dinesh Vyas
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

9.  Sex Differences in the Effect of Resveratrol on DSS-Induced Colitis in Mice.

Authors:  Alexandra Wagnerova; Janka Babickova; Robert Liptak; Barbora Vlkova; Peter Celec; Roman Gardlik
Journal:  Gastroenterol Res Pract       Date:  2017-03-29       Impact factor: 2.260

10.  Colonic and Hepatic Modulation by Lipoic Acid and/or N-Acetylcysteine Supplementation in Mild Ulcerative Colitis Induced by Dextran Sodium Sulfate in Rats.

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Orlando Roberto Pimentel de Araújo; Valéria Nunes-Souza; Juliana Célia de Farias Santos; Luiza Antas Rabelo; Marília Oliveira Fonseca Goulart
Journal:  Oxid Med Cell Longev       Date:  2016-11-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.